Bicoronal suture fusion constitutes the pathognomonic cranial hallmark of Apert syndrome, detectable sonographically from 18 gestational weeks. The most recognized manifestation is turribrachycephaly, characterized by a cranial index exceeding 90% (specificity 94%) and an abnormal fronto-occipital to biparietal diameter ratio >0.72, resulting in a towering cranial vault with frontal bossing (14). Crucially, modern ultrasound protocols now prioritize sutural biomarker analysis over isolated morphology assessment. Absence of the normal hypoechoic suture line, coupled with aberrant Doppler flow signals at coronal sutures, provides direct evidence of synostosis, reducing false positives from positional molding (10) (Figure 1).

Secondary intracranial signs further support diagnosis. The “copper-beaten” sign—inner table scalloping due to elevated intracranial pressure—is observed in 30% of cases after 26 weeks and correlates with postnatal ventriculomegaly risk (15). Recent technical advances enable earlier detection: high-frequency transvaginal probes (9–12 MHz) permit suture evaluation ≤16 weeks, identifying abnormal ossification centers in high-risk fetuses (16). This paradigm shift toward first-trimester risk stratification aligns with emerging evidence that cranial dysmorphogenesis initiates as early as 10–12 weeks in FGFR2-mutated embryos.

Three-dimensional ultrasound reconstruction with skeletal rendering mode (Classic, HDlive Silhouette) now quantifies suture fusion topography. Coronal synostosis typically extends 4–7 mm laterally from the sagittal midline, while associated lambdoid involvement manifests as posterior cranial flattening. Such precision facilitates differentiation from phenotypically overlapping syndromes like Saethre-Chotzen (unicoronal fusion) and Crouzon (multi-suture involvement without syndactyly) (9).

Midface retrusion in Apert syndrome represents a spectrum of deformities now quantifiable through standardized biometric approaches. Hypoplastic nasal bones, consistently reported as abnormally shortened in prenatal imaging, serve as a key diagnostic marker with high positive predictive value, outperforming subjective visual assessments (17). Concurrently, orbital hypertelorism (increased interorbital distance) and proptosis (anterior displacement of the globes) reflect impaired maxillary advancement, detectable via transorbital sonographic planes (18). The integration of three-dimensional angular phenotyping has refined diagnostic precision. A reduced maxilla-nasion-mandible angle demonstrates high specificity for severe midface deficiency and correlates strongly with postnatal airway compromise risk (19, 20). This shift to angular metrics aligns with developmental studies confirming FGFR2-mediated disruption of maxillary ossification centers as early as the first trimester. Computational modeling further validates that quantitative facial angle analysis provides earlier and more objective detection than traditional linear measurements (21) (Figure 2).

The prenatal assessment of syndactyly in Apert syndrome has evolved from static anatomical observation to dynamic functional evaluation (22). Traditional two-dimensional ultrasound primarily detects osseous fusion but exhibits limitations in visualizing cutaneous syndactyly due to technical constraints (23, 24). Advanced four-dimensional HDlive Flow imaging with spatiotemporal correlation overcomes these limitations by reconstructing perfusion patterns within fused digits (25). This technique discriminates Apert-specific “mitten hands” from other syndromic syndactylies by mapping unique vascular architectures, significantly improving diagnostic accuracy over conventional methods. Further refinement is achieved through reverse-mode rendering algorithms, which isolate osseous margins to reveal pathognomonic fourth metacarpal-phalangeal synostosis—a highly specific feature of Apert syndrome (26). Optimal visualization requires late-gestation imaging (>24 weeks), when digital ossification nears completion. Detection sensitivity progressively increases during this period, correlating with advancing skeletal maturation (27). Emerging artificial intelligence tools now automate digit segmentation, reducing operator-dependent variability in assessment (28, 29) (Figure 3).

Advanced MRI transcends structural imaging to prognosticate neurodevelopment. T2 HASTE sequences confirm ventriculomegaly (≥10 mm) in 58% of cases and corpus callosum hypoplasia in 42%, yet these lack predictive value for cognitive outcomes (12, 30). Diffusion tensor imaging (DTI) addresses this gap: reduced fractional anisotropy in corticospinal tracts (68% of FGFR2-mutated fetuses) correlates with postnatal motor deficits (r = −0.71, p < 0.001), establishing prenatal connectomics as a biomarker (13). For cranial assessment, CISS 3D sequences map suture fusion topography, differentiating bicoronal synostosis (Apert) from unicoronal (Saethre-Chotzen) with 93% concordance to postnatal CT (31–33).

The diagnostic odyssey for Apert syndrome has evolved from chromosomal banding techniques to precision genomics. Conventional karyotyping, historically employed to exclude aneuploidies, fails to detect FGFR2 point mutations—a critical limitation given that >98% of cases stem from FGFR2 exon 7 variants (p.Ser252Trp or p.Pro253Arg) (34, 35). Sanger sequencing of this hotspot remains the diagnostic gold standard, achieving near-complete (99.7%) sensitivity in prenatal amniocytes when combined with multiplex ligation-dependent probe amplification (MLPA) to rule out mosaicism (36). Non-invasive prenatal testing (NIPT) using targeted digital PCR analysis of cell-free fetal DNA (cffDNA) demonstrates potential for detecting FGFR2 p.Ser252Trp variants, though current sensitivity remains suboptimal (<90%) in clinical practice due to biological and technical constraints. Fetal fraction thresholds exceeding 8% are required for reliable analysis, limiting its applicability in early gestation (37, 38). For equivocal cases, rapid whole-exome sequencing (rWES) of amniotic fluid delivers results within 7 days, resolving 92% of craniosynostosis syndromes with undetermined ultrasound findings (39). This acceleration is pivotal: prenatal diagnosis before 22 weeks optimizes counseling windows for termination decisions in jurisdictions with gestational limits. Emerging third-generation sequencing technologies promise further transformation. Oxford Nanopore long-read sequencing discriminates FGFR2 haplotypes at allele fractions as low as 0.1%, enabling non-invasive phasing of de novo mutations (40). CRISPR-Cas9-mediated enrichment of specific fetal alleles in maternal plasma demonstrates in vitro potential to enhance detection sensitivity (41). However, due to the limitations of fetal DNA content, it is not feasible to completely replace invasive testing in the short term.

Parental Counselling: Prenatal diagnosis allows the parents to decide on the continuation or termination of pregnancy. It also makes early psychological and social support possible. Parents can be counselled on the expected outcome, possible complications, and the need for multidisciplinary management after birth (56). Delivery Planning: Knowledge of the diagnosis enables the practitioner to plan for the mode of delivery. In cases where there is severe craniosynostosis or suspicion of airway obstruction, consideration for cesarean delivery may be entertained to minimize birth trauma and to ensure immediate access to neonatal resuscitation and management (57). Multidisciplinary Management Activation: Prenatal diagnosis creates a unique window to engage key specialists—neonatologists, craniofacial surgeons, geneticists, and neurodevelopmental therapists—before birth, facilitating pre-delivery care planning and role assignment. This early activation ensures that the care team is prepared to address immediate postnatal needs (e.g., airway support, initial imaging) and establish a long-term care roadmap, which is critical for optimizing the affected child's functional outcomes (58).

Building upon these critical implications, the integration of key prenatal findings triggers a defined clinical action pathway. Prenatal suspicion arises from key ultrasound markers: turribrachycephaly, midface hypoplasia with hypertelorism, and symmetric “mitten hands/sock feet” syndactyly. Therefore, the identification of any of these features, particularly in combination, should not be viewed in isolation but should prompt a standardized diagnostic cascade. The immediate clinical actions following initial sonographic suspicion are twofold. First, a detailed, targeted ultrasound examination, preferentially employing 3D/4D modalities, should be performed to confirm and characterize the extent of anomalies. Second, this can be followed by a specialist fetal MRI to exclude associated structural brain anomalies and assess white matter microstructure, depending on clinical circumstances and resource availability. The definitive diagnostic step remains invasive testing via amniocentesis for targeted FGFR2 gene sequencing to confirm the molecular diagnosis. This sequential diagnostic approach—from ultrasound suspicion to molecular confirmation—ensures diagnostic rigor and immediately initiates the transition to coordinated care, including parental counseling, perinatal planning, and multidisciplinary postnatal management. To facilitate this integrated diagnostic and management approach, we propose a risk stratification diagnostic flowchart based on key sonographic findings and subsequent steps (Figure 4).

Given the high risk of airway obstruction in Apert syndrome secondary to severe midface hypoplasia and cranial base anomalies, pre-delivery mobilization of a dedicated Airway Multidisciplinary Assessment Team (AMAT) is essential (59). This team—integrating maternal-fetal medicine, neonatology, pediatric otolaryngology, and anesthesiology—systematically implements risk-stratified interventions: for critical cases, Ex Utero Intrapartum Treatment (EXIT) procedures with secured tracheostomy are prioritized to address immediate respiratory failure, utilizing real-time laryngoscopy to navigate anatomical complexities; for less severe phenotypes, nasopharyngeal intubation or Continuous Positive Airway Pressure (CPAP) support post-cesarean delivery proves effective (60). Consequently, the predominance of cesarean sections reflects proactive adaptation to turribrachycephalic cranial constraints, with this protocolized, team-based approach significantly mitigating neonatal mortality compared to historical ad hoc management (59).

Early cranial vault remodeling constitutes the cornerstone of infant management in Apert syndrome, driven by the imperative to mitigate intracranial hypertension and its irreversible neurocognitive sequelae. Given the accelerated calvarial fusion kinetics, fronto-orbital advancement is prioritized within the first year of life (61), where surgical release of fused sutures not only expands intracranial volume but also reconfigures the orbital framework to protect globes from exposure (62). Contemporary management has evolved, with growing emphasis on primary posterior cranial vault distraction osteogenesis (PCVDO) for initial treatment. Research indicates that PCVDO safely achieves significant cranial volume expansion (approximately 20%–25%) and effectively controls intracranial pressure, serving as a robust intervention that can delay the need for complex fronto-orbital advancement (FOA) (63–66). Alternatively, minimally invasive strip craniectomies performed before 6 months of age, followed by helmet therapy, have established a key role in early management. Multicenter studies confirm that various minimally invasive techniques reliably correct the scaphocephalic deformity by harnessing the brain's rapid growth potential for physiological calvarial remodeling (67–70). It is important to note that infantile surgical management encompasses multiple options—including early PCVDO, early minimally invasive strip craniectomies, or later FOA—and may involve combined procedures at distinct timepoints (71). Together, these approaches represent a strategic shift towards initial, less invasive procedures that prioritize neuroprotection and growth modulation, potentially reducing the burden of major reconstructive surgery in early infancy.

Concurrently, functional restoration of the extremities begins in this period. The initial and most critical step in syndactyly management—the release of the thumb and first web space—is typically performed around 6 months of age. This early intervention is fundamental for establishing basic grasp, a milestone that unlocks essential sensorimotor development and enables the infant's active interaction with their environment (72). To preemptively address neurodevelopmental vulnerability, serial diffusion tensor imaging monitors white matter integrity, while structured enrichment programs targeting sensorimotor pathways are initiated upon detecting aberrant neural trajectories (30). This integrated paradigm—surgically optimizing physical containment while actively nurturing neural plasticity and establishing early hand function—establishes the foundation for functional outcomes beyond mere survival.

Functional restoration during childhood focuses on correcting midfacial retrusion and digit coalescence to enable essential breathing, vision, and manual dexterity, while concurrently addressing psychosocial barriers to social integration. The management of progressive midface hypoplasia becomes a primary focus during this stage. As progressive midface hypoplasia exacerbates obstructive sleep apnea and corneal exposure—potentially fueling social withdrawal due to visible facial differences—Le Fort III advancement with distraction osteogenesis is strategically timed prior to permanent dentition eruption, thereby simultaneously expanding the nasopharyngeal airway while repositioning the orbits for protective globe coverage and mitigating stigma-associated anxiety (73). Following the initial procedures in infancy, syndactyly reconstruction continues throughout childhood. Staged web space releases beyond the first web prioritize functional commissure formation over cosmetic outcomes, specifically enabling participation in peer activities (e.g., writing, play) critical for self-esteem development (74, 75). Furthermore, sensory integration protocols address high-frequency hearing loss through ventilatory tube placement to prevent academic disengagement from auditory processing deficits, and implement speech therapy to overcome articulation barriers from palatal dysmorphology, explicitly targeting communicative confidence in classroom settings (59, 76). This coordinated triad of skeletal, digital, and communicative interventions transforms passive anatomical correction into active participation in daily activities, with embedded cognitive-behavioral strategies reinforcing resilience against appearance-related bullying (77–79). The integrated care pathway across these critical phases is summarized in Figure 5.